|
Controlled IL-12 in combination with a PD-1 inhibitor subjects with recurrent glioblastoma. |
|
|
Stock and Other Ownership Interests - DNAtrix; Immunomic Therapeutics; Seneca Therapeutics |
|
Consulting or Advisory Role - Advantagene; DNAtrix; InSightec; Merck; Sangamo Therapeutics; Voyager Therapeutics |
Research Funding - Amgen; Newlink Genetics |
Patents, Royalties, Other Intellectual Property - Patents related to oncolytic virus technology, gene therapy, microRNA, exosome, antibodies |
|
|
Consulting or Advisory Role - Abbvie; Eisai; Monteris Medical |
Speakers' Bureau - Novocure |
Research Funding - Bristol-Myers Squibb |
Expert Testimony - Loyola University Medical Center |
Travel, Accommodations, Expenses - Novocure |
Other Relationship - American Physician Institute; EBSCO; MedLink Neurology |
|
|
Consulting or Advisory Role - Monteris Medical |
Speakers' Bureau - Varian Medical Systems |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
Travel, Accommodations, Expenses - ZIOPHARM Oncology |
|
|
Employment - Epizyme; ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
Patents, Royalties, Other Intellectual Property - IL-12 |
Travel, Accommodations, Expenses - ZIOPHARM Oncology |
|
|
No Relationships to Disclose |
|
|
Employment - ZIOPHARM Oncology |
Travel, Accommodations, Expenses - ZIOPHARM Oncology |
|
|
Employment - Kiniksa; ZIOPHARM Oncology |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - Merck; Quest Diagnostics; ZIOPHARM Oncology |
Research Funding - ZIOPHARM Oncology |
Patents, Royalties, Other Intellectual Property - Ziopharm Oncology (Inst) |
|
|
Employment - MD Anderson Cancer Center; ZIOPHARM Oncology |
Leadership - ZIOPHARM Oncology |
Stock and Other Ownership Interests - CellChorus; CytoSen; Immatics; Secure Transfusion Services; Taro; ZIOPHARM Oncology |
Research Funding - ZIOPHARM Oncology |
Patents, Royalties, Other Intellectual Property - City of Hope; immatics; MD Anderson Cancer Center; Sangamo Bioscience |